HomeCompareNEMKY vs MRK

NEMKY vs MRK: Dividend Comparison 2026

NEMKY yields 0.81% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NEMKY wins by $566.0K in total portfolio value· pulled ahead in Year 6
10 years
NEMKY
NEMKY
● Live price
0.81%
Share price
$15.00
Annual div
$0.12
5Y div CAGR
88.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$622.8K
Annual income
$435,333.65
Full NEMKY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NEMKY vs MRK

📍 NEMKY pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNEMKYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NEMKY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NEMKY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NEMKY
Annual income on $10K today (after 15% tax)
$68.56/yr
After 10yr DRIP, annual income (after tax)
$370,033.60/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, NEMKY beats the other by $361,705.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NEMKY + MRK for your $10,000?

NEMKY: 50%MRK: 50%
100% MRK50/50100% NEMKY
Portfolio after 10yr
$339.8K
Annual income
$222,565.90/yr
Blended yield
65.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NEMKY
Analyst Ratings
2
Hold
Consensus: Hold
Altman Z
5.2
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NEMKY buys
0
MRK buys
0
No recent congressional trades found for NEMKY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNEMKYMRK
Forward yield0.81%2.76%
Annual dividend / share$0.12$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR88.5%32.7%
Portfolio after 10y$622.8K$56.8K
Annual income after 10y$435,333.65$9,798.13
Total dividends collected$585.6K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: NEMKY vs MRK ($10,000, DRIP)

YearNEMKY PortfolioNEMKY Income/yrMRK PortfolioMRK Income/yrGap
1$10,852$152.03$11,206$366.19$354.00MRK
2$11,902$290.65$12,650$502.35$748.00MRK
3$13,297$561.59$14,407$694.19$1.1KMRK
4$15,333$1,105.28$16,585$967.82$1.3KMRK
5$18,652$2,245.31$19,342$1,363.89$690.00MRK
6← crossover$24,769$4,811.63$22,913$1,947.19+$1.9KNEMKY
7$37,759$11,256.63$27,662$2,823.89+$10.1KNEMKY
8$70,634$30,231.02$34,159$4,173.35+$36.5KNEMKY
9$175,203$99,624.49$43,337$6,308.80+$131.9KNEMKY
10$622,800$435,333.65$56,776$9,798.13+$566.0KNEMKY

NEMKY vs MRK: Complete Analysis 2026

NEMKYStock

Nemetschek SE provides software solutions for architecture, engineering, construction, media, and entertainment markets in Germany, rest of Europe, the Americas, the Asia Pacific, and internationally. It operates through four segments: Design, Build, Manage, and Media & Entertainment. The Design segment offers software solutions primarily under the Allplan, Graphisoft, Solibri, Precast, Vectorworks, SCIA, dRofus, Data Design System, Frilo, and RISA brands for architects, designers, engineers, structural engineers, specialist planners, and landscape designers, as well as developers and general contractors. This segment provides building information modeling (BIM) solutions for computer aided design and computer aided engineering in 2D and 3D building design and imaging. The Build segment offers integrated complete 5D BIM solutions primarily under the Bluebeam brand that support bidding and awarding, invoicing, budgeting, scheduling, and cost calculation; and commercial enterprise resource planning solutions. This segment serves construction companies, developers, building supplies, and general contractors, as well as planning offices, architects, and civil engineers. The Manage segment provides commercial property management services under the Crem brand; and modular and integrated software solutions for property, facility, and workplace management under the Spacewell brand for facility and property managers, banks, and insurance and property companies; and intelligent smart building platform. The Media & Entertainment segment offers software solutions under the Maxon name for rendering 3D modeling, animation, and visual effects that are used in film, television, advertising, and video game productions, as well as in medicine, product design, and infographics. The company was founded in 1963 and is headquartered in Munich, Germany.

Full NEMKY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NEMKY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NEMKY vs SCHDNEMKY vs JEPINEMKY vs ONEMKY vs KONEMKY vs MAINNEMKY vs JNJNEMKY vs ABBVNEMKY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.